Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission

Molecular and Cellular Neuroscience

Volumn 17, Issue 6, 2001, Pages 1071-1083

  Battaglia, Giuseppe ^a   Bruno, Valeria ^a   Pisani, Antonio ^b,c   Centonze, Diego ^b,c   Catania, Maria Vincenza ^d   Calabresi, Paolo ^b,c   Nicoletti, Ferdinando ^a,e  

^a IRCCS NEUROMED   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d CNR   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 CARBOXY 2 METHYLPHENYLGLYCINE; GLUTAMATE RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROPHYSIOLOGY; GABAERGIC SYSTEM; MALE; MICRODIALYSIS; NEUROPHYSIOLOGY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0034948146     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2001.0992     Document Type: Article

References (36)

1. A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates
2. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
3. The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction
4. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4-carboxyphenylglycine (LY367385): Comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors
5. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective
6. Modulation of synaptic transmission and differential localisation of mGluRs in cultured hippocampal autapses
7. Synaptic and intrinsic control of membrane excitability of neostriatal neurons: II. An in vitro analysis
8. An enhanced expression of the immediate early gene, Egr-1, is associated with neuronal apoptosis in culture
9. 2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonizes metabotropic glutamate mGluR1 receptors
10. Pharmacology and functions of metabotropic glutamate receptors
11. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
12. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1
13. The mGlu receptor ligand (s)-4C3HPG protects neurons after global ischaemia in gerbils
14. Membrane properties and synaptic responses of rat striatal neurones in vitro
15. Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors
16. mGluR7-like receptor and GABA(B) receptor activation enhances neurotoxic effects of N-methyl-D-aspartate in cultured mouse striatal GABAergic neurons
17. CPCCOEt, a non-competitive mGluR1 antagonist, inhibits receptor signaling without affecting glutamate binding
18. Emerging insights into the genesis of epilepsy
19. Glutamate spillover suppresses inhibition by activating presynaptic mGluRs
20. Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA1
21. Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury
22. Metabotropic glutamate receptors: Synaptic transmission, modulation, and plasticity
23. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders?
24. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism
25. Subsynaptic localization of group I metabotropic glutamate receptors at glutamatergic synapses in monkey striatum
26. 1-Ammoindan-1,5-dicarboxylic acid and (s)-(+)-2-(3′-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia
27. Enhancement of NMDA responses by group-I metabotropic glutamate receptor activation in striatal neurones
28. (s)-4C3HPG reduces infarct size after focal cerebral ischemia
29. Kainate receptor modulation of GABA release involves a metabotropic function
30. Cytotoxicity in murine neocortical cell cultures
31. Pharmacological agents acting at subtypes of metabotropic glutamate receptors
32. Modulation of GABAergic signaling among interneurons by metabotropic glutamate receptors
33. Antagonists of group-I mGluRs attenuate excitotoxic neuronal death in cortical cultures
34. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons
35. SIB-1757 and SIB-1893: Selective, noncompetitive antagonists of metabotropic glutamate receptor type 5